Table 1.
Patient | Pre-Lorlatinib Plasma ALK Mutations | Post-Lorlatinib Plasma ALK Mutations |
---|---|---|
MGH9200 | L1196M | L1196M*, G1202R* |
MGH9035 | G1202R, L1196M, V1180L | G1202R*, L1196M*, C1156Y |
MGH9118 | D1203N | D1203N, G1123D |
MGH9158 | L1196Q^, L1196M^, G1202R^ | L1196M |
MGH087 | G1202R | G1202R |
MGH9185 | G1202R | I1171N, D1203N |
MGH9027 | I1171N | I1171N, D1203N |
MGH059 | E1210K*, I1171N, V1180L, L1196M* | E1210K*, L1196M* |
MGH9213 | L1196M | L1196M*, D1203N* |
MGH990 | G1202R, I1171N | I1171N, D1203N |
MGH9212 | I1171S, F1174L | I1171S, G1269A |
MGH919 | G1202R*, L1196M* | G1202R*, L1196M* |
MGH9176 | G1202R | G1202R |
MGH915 | None | None |
MGH964 | None | None |
Blue=mutation only seen in pre-lorlatinib specimen; Red=mutation only seen in post-lorlatinib specimen
ALK mutations occurred in cis
ALK mutations occurred in trans